These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 18095744)

  • 21. Are the Naranjo criteria reliable and valid for determination of adverse drug reactions in the intensive care unit?
    Kane-Gill SL; Kirisci L; Pathak DS
    Ann Pharmacother; 2005 Nov; 39(11):1823-7. PubMed ID: 16204392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inter-expert agreement of seven criteria in causality assessment of adverse drug reactions.
    Arimone Y; Miremont-Salamé G; Haramburu F; Molimard M; Moore N; Fourrier-Réglat A; Bégaud B
    Br J Clin Pharmacol; 2007 Oct; 64(4):482-8. PubMed ID: 17711539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of the Liverpool Adverse Drug Reaction Avoidability Assessment Tool.
    Bracken LE; Nunn AJ; Kirkham JJ; Peak M; Arnott J; Smyth RL; Pirmohamed M; Turner MA
    PLoS One; 2017; 12(1):e0169393. PubMed ID: 28046035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel.
    Macedo AF; Marques FB; Ribeiro CF; Teixeira F
    Pharmacoepidemiol Drug Saf; 2005 Dec; 14(12):885-90. PubMed ID: 16059869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury.
    García-Cortés M; Lucena MI; Pachkoria K; Borraz Y; Hidalgo R; Andrade RJ;
    Aliment Pharmacol Ther; 2008 May; 27(9):780-9. PubMed ID: 18284654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the reproducibility of the Naranjo Adverse Drug Reaction Probability Scale score in published case reports.
    Liang R; Borgundvaag B; McIntyre M; Thwaites C; Ragan K; Wyllie A
    Pharmacotherapy; 2014 Nov; 34(11):1159-66. PubMed ID: 25266970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the MOdified NARanjo Causality Scale (MONARCSi) for Individual Case Safety Reports vs. a Reference Standard.
    Comfort SM; Donzanti B; Dorrell D; Dhar S; Eden C; Donaldson F
    Drug Saf; 2022 Dec; 45(12):1529-1538. PubMed ID: 36273375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary Results of a Novel Algorithmic Method Aiming to Support Initial Causality Assessment of Routine Pharmacovigilance Case Reports for Medication-Induced Liver Injury: The PV-RUCAM.
    Scalfaro E; Streefkerk HJ; Merz M; Meier C; Lewis D
    Drug Saf; 2017 Aug; 40(8):715-727. PubMed ID: 28508325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First experiences with a tool to measure the level of clinical information present in adverse drug reaction reports.
    Oosterhuis I; Rolfes L; Ekhart C; Muller-Hansma A; Härmark L
    Expert Opin Drug Saf; 2018 Feb; 17(2):111-115. PubMed ID: 29157026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic adverse drug reactions: a case/non-case study in Italy.
    Motola D; Vargiu A; Leone R; Cocci A; Salvo F; Ros B; Meneghelli I; Venegoni M; Cutroneo PM; Vaccheri A; Velo G; Montanaro N
    Eur J Clin Pharmacol; 2007 Jan; 63(1):73-9. PubMed ID: 17119945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Validation of a measurement scale: example of a French Adverse Drug Reactions Preventability Scale].
    Olivier P; Caron J; Haramburu F; Imbs JL; Jonville-Béra AP; Lagier G; Sgro C; Vial T; Montastruc JL; Lapeyr-Mestre M
    Therapie; 2005; 60(1):39-45. PubMed ID: 15929472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The utility of the World Health Organization-The Uppsala Monitoring Centre (WHO-UMC) system for the assessment of adverse drug reactions in hospitalized children.
    Tantikul C; Dhana N; Jongjarearnprasert K; Visitsunthorn N; Vichyanond P; Jirapongsananuruk O
    Asian Pac J Allergy Immunol; 2008; 26(2-3):77-82. PubMed ID: 19054924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse drug reactions: physicians' opinions versus a causality assessment method.
    Miremont G; Haramburu F; Bégaud B; Péré JC; Dangoumau J
    Eur J Clin Pharmacol; 1994; 46(4):285-9. PubMed ID: 7957509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Causal or casual? The role of causality assessment in pharmacovigilance.
    Meyboom RH; Hekster YA; Egberts AC; Gribnau FW; Edwards IR
    Drug Saf; 1997 Dec; 17(6):374-89. PubMed ID: 9429837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation and Reproducibility of the Updated French Causality Assessment Method: an Evaluation by Pharmacovigilance Centres & Pharmaceutical Companies.
    Théophile H; Dutertre JP; Gérardin M; Valnet-Rabier MB; Bidault I; Guy C; Haramburu F; Hillaire-Buys D; Méglio C; Arimone Y
    Therapie; 2015; 70(5):465-76. PubMed ID: 26423144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methods for evaluating adverse drug event preventability in emergency department patients.
    Woo SA; Cragg A; Wickham ME; Peddie D; Balka E; Scheuermeyer F; Villanyi D; Hohl CM
    BMC Med Res Methodol; 2018 Dec; 18(1):160. PubMed ID: 30514232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
    Jose J; Rao PG
    Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Updating the French method for the causality assessment of adverse drug reactions.
    Arimone Y; Bidault I; Dutertre JP; Gérardin M; Guy C; Haramburu F; Hillaire-Buys D; Meglio C; Penfornis C; Théophile H; Valnet-Rabier MB;
    Therapie; 2013; 68(2):69-76. PubMed ID: 23773347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An updated method improved the assessment of adverse drug reaction in routine pharmacovigilance.
    Théophile H; André M; Arimone Y; Haramburu F; Miremont-Salamé G; Bégaud B
    J Clin Epidemiol; 2012 Oct; 65(10):1069-77. PubMed ID: 22910538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of causal inference in forensic medicine.
    Meilia PDI; Freeman MD; Herkutanto ; Zeegers MP
    Forensic Sci Med Pathol; 2020 Jun; 16(2):313-320. PubMed ID: 32157581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.